Analyst Ratings for Cincor Pharma Inc (CINC)
CINC Rating Summary
CINC Price Target Summary
- Highest: $73.00 (Piper Sandler)
- Lowest: $22.00 (Morgan Stanley)
- Average: $40.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$40.40 (+37.9%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
Avg. $ Target:
$40.40 (+37.9%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/12/2023 | Barclays | Leon Wang | Downgrade | Equalweight (Overweight) |
31.00 (22.00) |
28.80 (29.29) |
1.7% | Details |
| 11/29/2022 | Oppenheimer | Jay Olson | Downgrade | Perform (Outperform) |
N/A (N/A) |
26.53 (29.29) |
10.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
